Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Neurogene Inc.(NGNE) | 1,004,291 | 1,004,291 | 0 | $36.55M | $42.14M | 12.72% | +$5.59M |
| ABIVAX Société AnonymeADS(ABVX) | 2,472,188 | 2,128,773 | -343,415 | $32.68M | $24.52M | 7.40% | -$8.16M |
| Pliant Therapeutics, Inc.(PLRX) | 2,636,864 | 1,910,121 | -726,743 | $28.35M | $21.41M | 6.46% | -$6.93M |
| Evolus, Inc.(EOLS) | 2,451,772 | 1,170,000 | -1,281,772 | $26.60M | $18.95M | 5.72% | -$7.65M |
| Viridian Therapeutics, Inc.(VRDN) | 500,000 | 750,000 | +250,000 | $6.50M | $17.06M | 5.15% | +$10.56M |
| Cytokinetics, Incorporated(CYTK) | 474,202 | 316,000 | -158,202 | $25.69M | $16.68M | 5.03% | -$9.01M |
| Kalvista Pharmaceuticals Inc | 1,338,568 | 1,299,503 | -39,065 | $15.77M | $15.05M | 4.54% | -$720.1K |
| Dynavax Technologies Corp | 2,374,000 | 1,326,234 | -1,047,766 | $26.66M | $14.77M | 4.46% | -$11.89M |
| Context Therapeutics Inc.(CNTX) | 7,419,355 | 6,934,982 | -484,373 | $14.88M | $13.59M | 4.10% | -$1.28M |
| Zura Bio LimitedCL A(ZURA) | 4,642,241 | 3,263,672 | -1,378,569 | $16.25M | $13.25M | 4.00% | -$3.00M |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 514,659 | +514,659 | $0 | $12.61M | 3.81% | +$12.61M |
| Merus N V | 523,288 | 250,000 | -273,288 | $30.96M | $12.49M | 3.77% | -$18.47M |
| Olema Pharmaceuticals, Inc.(OLMA) | 796,880 | 1,000,000 | +203,120 | $8.62M | $11.94M | 3.60% | +$3.32M |
| Ionis Pharmaceuticals, Inc.(IONS) | 330,000 | 255,000 | -75,000 | $15.73M | $10.22M | 3.08% | -$5.51M |
| Autolus Therapeutics plcADS(AUTL) | 3,441,667 | 2,811,955 | -629,712 | $11.98M | $10.21M | 3.08% | -$1.77M |
| UroGen Pharma Ltd.(URGN) | 2,906,259 | 758,786 | -2,147,473 | $48.77M | $9.64M | 2.91% | -$39.13M |
| Optinose Inc | 13,727,097 | 12,861,136 | -865,961 | $14.28M | $8.62M | 2.60% | -$5.66M |
| Arcellx Inc COMMON STOCK | 492,000 | 100,000 | -392,000 | $27.15M | $8.35M | 2.52% | -$18.80M |
| Dianthus Therapeutics, Inc.(DNTH) | 757,929 | 275,000 | -482,929 | $19.62M | $7.53M | 2.27% | -$12.09M |
| Outlook Therapeutics, Inc.(OTLK) | 1,701,510 | 1,293,028 | -408,482 | $12.56M | $6.90M | 2.08% | -$5.65M |
| Jasper Therapeutics, Inc.(JSPR) | 402,015 | 322,380 | -79,635 | $9.13M | $6.06M | 1.83% | -$3.06M |
| Voyager Therapeutics, Inc.(VYGR) | 1,601,527 | 959,953 | -641,574 | $12.67M | $5.62M | 1.69% | -$7.05M |
| Helix Acquisition Corp IiCL A | 500,000 | 500,000 | 0 | $5.11M | $5.22M | 1.58% | +$115.0K |
| TScan Therapeutics, Inc.(TCRX) | 940,831 | 1,016,375 | +75,544 | $5.50M | $5.06M | 1.53% | -$442.3K |
| Unicycive Therapeutics Inc | 0 | 8,559,000 | +8,559,000 | $0 | $3.49M | 1.05% | +$3.49M |
| Promis Neurosciences Inc | 0 | 2,790,698 | +2,790,698 | $0 | $3.49M | 1.05% | +$3.49M |
| Cartesian Therapeutics, Inc.(RNAC) | 0 | 200,000 | +200,000 | $0 | $3.22M | 0.97% | +$3.22M |
| Vistagen Therapeutics, Inc.(VTGN) | 1,529,338 | 674,075 | -855,263 | $5.32M | $2.03M | 0.61% | -$3.29M |
| Climb Bio, Inc.(CLYM) | 0 | 248,168 | +248,168 | $0 | $1.26M | 0.38% | +$1.26M |
| Amicus Therapeutics Inc COM | 1,495,500 | 0 | -1,495,500 | $14.84M | $0 | — | -$14.84M |
| Anaptysbio Inc | 25,000 | 0 | -25,000 | $626.5K | $0 | — | -$626.5K |
| Esperion Therapeutics Inc Ne | 5,791,594 | 0 | -5,791,594 | $12.86M | $0 | — | -$12.86M |
| Insmed Incorporated(INSM) | 250,000 | 0 | -250,000 | $16.75M | $0 | — | -$16.75M |
| Kyverna Therapeutics, Inc.(KYTX) | 499,152 | 0 | -499,152 | $3.74M | $0 | — | -$3.74M |
| Lexicon Pharmaceuticals, Inc.(LXRX) | 30,000 | 0 | -30,000 | $50.4K | $0 | — | -$50.4K |
| Puma Biotechnology, Inc.(PBYI) | 1,486,544 | 0 | -1,486,544 | $4.85M | $0 | — | -$4.85M |
| Spyre Therapeutics, Inc.(SYRE) | 134,612 | 0 | -134,612 | $3.16M | $0 | — | -$3.16M |
| Terns Pharmaceuticals Inc | 1,149,406 | 0 | -1,149,406 | $7.83M | $0 | — | -$7.83M |